Coste-efectividad de la adición de acarbosa al tratamiento de pacientes con diabetes tipo 2 en España Cost-effectiveness of the addition of acarbose to the treatment of patients wi... by Carme Piñol, Stephane Roze, William Valentine, Thomas Evers

Get full text

Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France. by Marine Sivignon, Rémi Monnier, Bertrand Tehard, Stéphane Roze

Get full text

Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries by Juliane Zemdegs, Alison Iroz, Mariacristina Vecchio, Stephane Roze, Yair Lotan

Get full text

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France by Audrey Petitjean, Jayne Smith-Palmer, William Valentine, Bertrand Tehard, Stephané Roze

Get full text

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France by Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman, Peter M Lync, Stephane Roze

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada by Hamza Alshannaq, John J Isitt, Richard F Pollock, Gregory J Norman, Greg Cogswell, Peter M Lynch, Stephane Roze